Effect of antidepressants on spatial memory deficit induced by dizocilpine

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Cognitive deficits are a primary symptom of schizophrenia, impacting patient outcomes.
• The efficacy of antidepressants in treating these cognitive symptoms remains debated.
• Dizocilpine administration in adolescent rats models schizophrenia-related cognitive impairments.

Purpose of the Study:

• To investigate the therapeutic potential of six antidepressants on cognitive deficits in a rat model of schizophrenia.
• To explore the underlying neurobiological mechanisms, specifically focusing on hippocampal parvalbumin interneurons.

Main Methods:

• Adolescent rats were treated with dizocilpine to induce cognitive deficits.
• Treated groups received one of six antidepressants (fluvoxamine, sertraline, paroxetine, escitalopram, venlafaxine, mirtazapine) or vehicle.
• Spatial memory was assessed using the Morris water maze (MWM), and hippocampal parvalbumin (PV) interneuron density was quantified.

Main Results:

• Fluvoxamine and escitalopram significantly improved spatial memory deficits induced by dizocilpine.
• These two antidepressants also reversed the reduction in hippocampal PV interneuron density caused by dizocilpine.
• Other tested antidepressants did not show significant effects on spatial memory or PV interneuron density.

Conclusions:

• Fluvoxamine and escitalopram demonstrate a therapeutic effect on cognitive deficits in a schizophrenia rat model.
• The normalization of hippocampal PV interneurons by these antidepressants suggests a neuroprotective role.
• These findings support the potential of specific antidepressants in managing cognitive impairments associated with schizophrenia.